Gland Pharma`s Generic Nelarabine Receives Approval in the U.S.
Nexus's Generic Nelarabine Receives Approval in the U.S.
Amneal's Generic Nelarabine Approval in the U.S.
Shorla Oncology, a privately-held, female founded US-Ireland pharmaceutical company, today announced that the US Food and Drug Administration (FDA) has approved the company’s oncology drug, Nelarabine Injection, for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Kindos' Generic Nelarabine Receives Approval in the U.S.
Dr. Reddy's Generic Nelarabine Receives Approval in the U.S.
MALVERN, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: nOCGN), a biopharmaceutical company focused on discovering, developing, nand commercializing novel therapeutics and vaccines, announced that the nU.S. Food and Drug Administration (FDA) has issued a clinical hold on nthe Company’s Investigational New Drug application (IND) to evaluate thenCOVID-19 vaccine candidate, BBV152, known as COVAXIN™ outside the nUnited States.
Zydus Pharma`s Generic Nelarabine Receives Approval In US
Zydus Cadila has received final approval from the US FDA to market nelarabine injection 250MG/50ML in the United States.
A research team led by the University of Kent and Goethe-University Frankfurt am Main, has solved an almost 40-year old mystery in leukaemia therapy and the drug nelarabine.